loading

Finanzdaten der Eledon Pharmaceuticals Inc-Aktie (ELDN)

Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
Enddatum des Zeitraums 2025-09-30 2025-06-30 2025-03-31 2024-12-31 2024-09-30
Periodenlänge 3 Monate 3 Monate 3 Monate 3 Monate 3 Monate
Revenues
-
- - - -
Operating Expenses
22.90%
19.07
24.73 17.96 24.70 20.51
Operating Income/Loss
22.90%
-19.07
-24.73 -17.96 - -20.51
Income/Loss From Continuing Operations Before Tax
55.66%
-17.46
-11.22 -6.495 -44.19 76.97
Income/Loss From Continuing Operations After Tax
55.66%
-17.46
-11.22 -6.495 -44.62 76.97
Net Income/Loss
55.66%
-17.46
-11.22 -6.495 -44.62 76.97
Preferred Stock Dividends And Other Adjustments
-1.329
- - -2.882 22.54
Attributable To Noncontrolling Interest
-
- - - -
Basic Average Shares
0.00%
77.16
77.16 77.13 7.1007 51.95
Diluted Average Shares
0.00%
77.16
77.16 77.13 5.437 55.48
Basic Earnings Per Share
61.54%
-0.21
-0.13 -0.08 -0.88 1.05
Diluted Earnings Per Share
61.54%
-0.21
-0.13 -0.08 0.67 -0.32
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-1.329
- - -5.764 45.08
$45.87
price up icon 0.18%
$28.99
price up icon 1.33%
$54.07
price up icon 1.61%
$90.20
price up icon 0.16%
$139.44
price down icon 0.28%
biotechnology ONC
$288.30
price up icon 0.99%
Kapitalisierung:     |  Volumen (24h):